What is Neonc Technologies Holdings's market cap?

Neonc Technologies Holdings (NTHI) has a market capitalization of $89.9M and trades on NASDAQ.

Who are Neonc Technologies Holdings's competitors?

Neonc Technologies Holdings's key competitors include Bristol-Myers Squibb Company, Pfizer Inc., Merck & Co., Inc., and others. These companies compete in similar markets and product categories.

Who does Neonc Technologies Holdings partner with?

Neonc Technologies Holdings's notable partners include University of Southern California, Quazar Investment Group, ClinDatrix, Inc., and others.

What subsidiaries does Neonc Technologies Holdings have?

Neonc Technologies Holdings's subsidiaries include NeOnc Technologies, Inc..

Where is Neonc Technologies Holdings headquartered?

Neonc Technologies Holdings is headquartered in United States of America. It has been publicly traded since 2025.

Neonc Technologies Holdings (NTHI) Stock Fundamentals

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company specializing in the development of novel drug candidates and delivery methods for intracranial malignancies.

Market cap

$89.87M-57.7%

Net income-$47.2M-11.2%

EPS (diluted)-$2.13+8.6%

Trailing twelve months · change vs. prior year

Earnings

Q2 2026 report

August 10, 2026

Revenue-EPS-$0.58Miss by $0.46

Read the full report

Next report

Nov 12, 2026 (In 1 week)

EPS estimate-$0.25

Financials

Q2 2026

Income statement

See full

Revenue-—

Operating income-$14.1M-146%

Net income-$14.2M-151%

EPS (diluted)-$0.58-93.3%

Balance sheet

See full

Cash & equivalents$2.0M+1,478%

Total debt$648.2K+63.9%

Total equity-$18.5M-56.8%

Total assets$5.2M+75.1%

Cash flow

See full

Operating cash flow-$4.8M+10.3%

Valuation & ratios

Valuation

See full

Market cap$89.87M-57.7%

Enterprise value$88.55M-54.7%

Returns & leverage

See full

Current ratio0.2×+0.1×

Competitors

By market cap

Merck & Co.$361.02B+67.5%

Pfizer$170.71B+23.6%

Bristol-Myers Squibb$125.49B+35.1%

Nuvectis Pharma, Inc.$606.2M+259%

NTH

Neonc Technologies Holdings$89.9M-54.2%

Oncolytics Biotech, Inc.$56.1M-53.7%

NXT

NextCure, Inc.$29.9M-8.9%

CNS Pharmaceuticals$7.0M-52.4%

By revenue growth

Merck & Co.+4.9%

Bristol-Myers Squibb+4.2%

Pfizer-0.2%

By net margin

Bristol-Myers Squibb18.47%+6.0pp

Pfizer15.65%—

Merck & Co.4.77%—

NTH

Neonc Technologies Holdings-51,613.33%—

Profile

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company specializing in the development of novel drug candidates and delivery methods for intracranial malignancies. The company focuses on overcoming the blood-brain barrier to treat primary and secondary brain cancers using proprietary intranasal and intra-arterial delivery pathways. Its core value proposition lies in enhancing the central nervous system penetration of chemotherapeutic agents while minimizing systemic toxicity.

Competitive position

A clinical-stage innovator focused on niche CNS delivery technologies and bioconjugated hybrid molecules for hard-to-treat brain malignancies.

GeographiesUnited States, Gulf Cooperation Council region

Customer segmentsPatients, Hospitals, Research Centers

Business modelR&D, Licensing, Biopharmaceutical Development

SuppliersContract Research Organizations (CROs), Third-party contract manufacturers, Academic research institutions, Raw material suppliers

CustomersOncology clinics, Specialty hospitals, Pharmaceutical companies for potential licensing

CountryUnited States of America

Listed2025

CEOAmir Farrokh Heshmatpour

SectorHealthcare

IndustryBiotechnology

Websiteneonctech.com

FilingsSEC EDGAR

FAQ

What is Neonc Technologies Holdings's market cap?: Neonc Technologies Holdings (NTHI) has a market capitalization of $89.9M and trades on NASDAQ.
Who are Neonc Technologies Holdings's competitors?: Neonc Technologies Holdings's key competitors include Bristol-Myers Squibb Company, Pfizer Inc., Merck & Co., Inc., and others. These companies compete in similar markets and product categories.
Who does Neonc Technologies Holdings partner with?: Neonc Technologies Holdings's notable partners include University of Southern California, Quazar Investment Group, ClinDatrix, Inc., and others.
What subsidiaries does Neonc Technologies Holdings have?: Neonc Technologies Holdings's subsidiaries include NeOnc Technologies, Inc..
Where is Neonc Technologies Holdings headquartered?: Neonc Technologies Holdings is headquartered in United States of America. It has been publicly traded since 2025.